Recall Record

Sinnar, Nashik District, N/A, India

Mylan Laboratories Limited, (Nashik FDF) recalls

1 recall recorded since 2018, most recently on 4 December 2018. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls1
Ongoing (FDA)1
Terminated or completed0
Class I (FDA)0

Ongoing Class II Drugs

Recall started
4 December 2018
Reason
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
Distribution
Product was distributed throughout the United States to several major distributors, including Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0332-2019, D-0330-2019, D-0329-2019, D-0327-2019, D-0325-2019, D-0321-2019, D-0326-2019, D-0328-2019, D-0320-2019, D-0322-2019, D-0331-2019, D-0324-2019 and 1 more

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.